Springhood

NeoPrediX develops decision support tools and digital health solutions for maternal, neonatal, and perinatal screening to evaluate, optimize, and personalize medical strategies in pediatrics. It translates medical data into intelligent predictions using advanced algorithms to support clinical decisions in neonatal and perinatal care, enabling practitioners to tailor treatments in early life and reduce the risk of long-term complications.

Founded in 2016, Nicolette develops a patient empowerment platform that visualizes complex medical data. Its first product, NicoBoard, is designed for NICU parents, providing visualized health data, curated research, and engagement tools to enable them to actively participate in their baby's care.

Mesentech Inc. is a regenerative medicine company based in Vancouver, Canada, focused on developing innovative therapies for bone-related diseases. Established in 2013, the company specializes in a prodrug platform that delivers therapeutics selectively to bone, addressing challenges associated with conventional drug delivery methods. Mesentech's lead product, MES1007, is a bone-targeted prodrug of a prostaglandin mimetic that aims to reverse bone loss associated with conditions such as osteoporosis and Duchenne muscular dystrophy. The company's proprietary technology enhances the delivery of small-molecule and biological drugs to the bone's surface and interior, allowing for more effective treatment while minimizing side effects. This approach is particularly significant given the inherent difficulty in accessing bone tissue due to its hard surface and low porosity. Mesentech's focus on selective drug delivery not only aims to improve treatment efficacy but also hopes to accelerate bone healing and address complications associated with low bone density disorders.

Argus Cognitive develops virtual medical instruments powered by intelligent virtual sensors. Its technology quantifies organ-level, system-level, and patient-level function, enabling medical professionals to make better-informed clinical decisions.

Founded in 2014, THINKMD develops a point-of-care clinical assessment tool called MEDSINC. This tool enables non-healthcare professionals to gather patient information, assess illness severity, and provide approved treatment recommendations. It also integrates real-time public health data and geo-location tracking.

Prapela is a pediatric medical device company focused on enhancing the health of newborns through noninvasive stimulation therapy. Its primary product, a reusable pad designed for placement in hospital bassinets or incubators, provides gentle stimulation that aids in regulating breathing control and improving oxygenation. By addressing common clinical issues such as irregular breathing and low oxygen levels, Prapela aims to improve cardiorespiratory outcomes for infants while reducing the need for pharmacotherapy and minimizing the duration of conventional treatments. Since its inception, Prapela has gained recognition as a leading innovator in the pediatric medical device sector, collaborating with neonatologists, the National Institutes of Health, and the FDA to advance its mission of improving newborn health.

Founded in 2014, Aldatu Biosciences specializes in adaptive PCR diagnostics for global health. Its proprietary PANDAA technology enables detection of highly variable genomic regions, empowering healthcare providers to improve patient outcomes and reduce costs, particularly in HIV care.